↓ Skip to main content

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes

Overview of attention for article published in Arthritis Research & Therapy, April 2020
Altmetric Badge

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes
Published in
Arthritis Research & Therapy, April 2020
DOI 10.1186/s13075-020-02163-6
Pubmed ID
Authors

Cem Gabay, Gerd R. Burmester, Vibeke Strand, Jérôme Msihid, Moshe Zilberstein, Toshio Kimura, Hubert van Hoogstraten, Susan H. Boklage, Jonathan Sadeh, Neil M. H. Graham, Anita Boyapati

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 11%
Student > Bachelor 6 10%
Other 5 8%
Professor 5 8%
Student > Master 3 5%
Other 8 13%
Unknown 29 46%
Readers by discipline Count As %
Medicine and Dentistry 15 24%
Nursing and Health Professions 4 6%
Unspecified 3 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 7 11%
Unknown 32 51%